Anumana, a joint venture between EHR data company nference and the Mayo Clinic, entered into a multiyear partnership with Pfizer to develop an AI-based tool for the early detection of cardiac amyloidosis.
Under the agreement, Anumana will research and pursue FDA De Novo classification for an algorithm that could find signals within electrocardiograms (ECGs) that hint at the condition. The...
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, announced this week it had purchased NeuTrace, which focused on developing AI applications for assessing electrical signals in the heart.
The deal includes the NeuTrace EP Data Biome, a platform designed to link devices and AI tools during electrophysiology procedures, as well as AI applications in development that...
Anumana, a joint venture between EHR data company nference and the Mayo Clinic, announced last week it had entered a strategic partnership with pharma giant Novartis to develop artificial intelligence tools to detect cardiovascular diseases.
The collaboration will focus on deploying AI algorithms that analyze ECGs to find left ventricular dysfunction, which can lead to heart failure, and...
Amazon Web Services is now accepting applications for the latest cohort of its Healthcare Accelerator, which this year will target improving health outcomes for underserved communities.
The accelerator will accept 10 startups focused on increasing access to healthcare, reducing disparities by managing social determinants of health and using data for equity in healthcare. The companies will...
